Sideward contact tracing and the control of epidemics in large gatherings.


Journal

Journal of the Royal Society, Interface
ISSN: 1742-5662
Titre abrégé: J R Soc Interface
Pays: England
ID NLM: 101217269

Informations de publication

Date de publication:
05 2022
Historique:
entrez: 10 5 2022
pubmed: 11 5 2022
medline: 14 5 2022
Statut: ppublish

Résumé

Effective contact tracing is crucial to containing epidemic spreading without disrupting societal activities, especially during a pandemic. Large gatherings play a key role, potentially favouring superspreading events. However, the effects of tracing in large groups have not been fully assessed so far. We show that in addition to forward tracing, which reconstructs to whom the disease spreads, and backward tracing, which searches from whom the disease spreads, a third 'sideward' tracing is always present, when tracing gatherings. This is an indirect tracing that detects infected asymptomatic individuals, even if they have been neither directly infected by nor directly transmitted the infection to the index case. We analyse this effect in a model of epidemic spreading for SARS-CoV-2, within the framework of simplicial activity-driven temporal networks. We determine the contribution of the three tracing mechanisms to the suppression of epidemic spreading, showing that sideward tracing induces a non-monotonic behaviour in the tracing efficiency, as a function of the size of the gatherings. Based on our results, we suggest an optimal choice for the sizes of the gatherings to be traced and we test the strategy on an empirical dataset of gatherings on a university campus.

Identifiants

pubmed: 35537473
doi: 10.1098/rsif.2022.0048
pmc: PMC9090492
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

20220048

Références

Nat Phys. 2021 May;17:652-658
pubmed: 34367312
BMC Med. 2020 Jul 30;18(1):240
pubmed: 32727547
Nature. 2021 Jan;589(7840):82-87
pubmed: 33171481
Phys Rev Lett. 2021 Mar 5;126(9):098301
pubmed: 33750152
JAMA Netw Open. 2021 Jan 4;4(1):e2035057
pubmed: 33410879
N Engl J Med. 2020 Apr 30;382(18):1708-1720
pubmed: 32109013
Am J Epidemiol. 2013 Dec 1;178(11):1655-62
pubmed: 24100954
Phys Rev Lett. 2018 Nov 30;121(22):228301
pubmed: 30547619
Wellcome Open Res. 2020 Oct 13;5:239
pubmed: 33154980
Science. 2021 Apr 9;372(6538):
pubmed: 33658326
Phys Rev E. 2017 Oct;96(4-1):042310
pubmed: 29347564
Nat Commun. 2019 Jun 6;10(1):2485
pubmed: 31171784
Phys Rev E. 2020 Aug;102(2-1):020301
pubmed: 32942487
PLoS Biol. 2020 Nov 12;18(11):e3000897
pubmed: 33180773
Lancet Infect Dis. 2021 Aug;21(8):1073-1074
pubmed: 34089651
PLoS Med. 2020 Jul 17;17(7):e1003193
pubmed: 32678827
Proc Natl Acad Sci U S A. 2020 Jul 7;117(27):15530-15535
pubmed: 32554604
Sci Rep. 2016 Oct 24;6:35724
pubmed: 27774998
J Infect. 2021 Jan;82(1):36-40
pubmed: 33245943
Commun Med (Lond). 2021 Dec 6;1:57
pubmed: 35602184
Econ Disaster Clim Chang. 2020;4(3):431-451
pubmed: 32838118
Proc Natl Acad Sci U S A. 2020 Jul 28;117(30):17513-17515
pubmed: 32632012
Nature. 2021 Feb;590(7847):544-546
pubmed: 33623168
Sci Rep. 2012;2:469
pubmed: 22741058
Nat Med. 2020 Nov;26(11):1714-1719
pubmed: 32943787
Lancet Infect Dis. 2020 Jun;20(6):656-657
pubmed: 32199493
PLoS Comput Biol. 2016 Apr 05;12(4):e1004836
pubmed: 27046030
Proc Natl Acad Sci U S A. 2016 Sep 6;113(36):9977-82
pubmed: 27555584
Nat Commun. 2021 Jan 11;12(1):232
pubmed: 33431829
Sci Rep. 2021 Mar 29;11(1):7028
pubmed: 33782492
Nature. 2021 Feb;590(7844):134-139
pubmed: 33348340
Proc Natl Acad Sci U S A. 2004 Apr 20;101(16):6146-51
pubmed: 15071187
Nat Med. 2020 May;26(5):640-642
pubmed: 32273610
J R Soc Interface. 2022 May;19(190):20220048
pubmed: 35537473
MMWR Morb Mortal Wkly Rep. 2020 Apr 10;69(14):411-415
pubmed: 32271722
Nature. 2021 May;593(7858):266-269
pubmed: 33767447
Nature. 2020 Aug;584(7821):425-429
pubmed: 32604404
Nat Commun. 2021 Mar 26;12(1):1919
pubmed: 33772002
PLoS Med. 2008 Mar 25;5(3):e74
pubmed: 18366252

Auteurs

Marco Mancastroppa (M)

Dipartimento di Scienze Matematiche, Fisiche e Informatiche, Università degli Studi di Parma, Parco Area delle Scienze, 7/A 43124 Parma, Italy.
INFN, Sezione di Milano Bicocca, Gruppo Collegato di Parma, Parco Area delle Scienze, 7/A 43124 Parma, Italy.

Andrea Guizzo (A)

Dipartimento di Scienze Matematiche, Fisiche e Informatiche, Università degli Studi di Parma, Parco Area delle Scienze, 7/A 43124 Parma, Italy.
INFN, Sezione di Milano Bicocca, Gruppo Collegato di Parma, Parco Area delle Scienze, 7/A 43124 Parma, Italy.

Claudio Castellano (C)

Istituto dei Sistemi Complessi (ISC-CNR), Via dei Taurini 19, I-00185 Roma, Italy.

Alessandro Vezzani (A)

Dipartimento di Scienze Matematiche, Fisiche e Informatiche, Università degli Studi di Parma, Parco Area delle Scienze, 7/A 43124 Parma, Italy.
INFN, Sezione di Milano Bicocca, Gruppo Collegato di Parma, Parco Area delle Scienze, 7/A 43124 Parma, Italy.
Istituto dei Materiali per l'Elettronica ed il Magnetismo (IMEM-CNR), Parco Area delle Scienze, 37/A 43124 Parma, Italy.

Raffaella Burioni (R)

Dipartimento di Scienze Matematiche, Fisiche e Informatiche, Università degli Studi di Parma, Parco Area delle Scienze, 7/A 43124 Parma, Italy.
INFN, Sezione di Milano Bicocca, Gruppo Collegato di Parma, Parco Area delle Scienze, 7/A 43124 Parma, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH